ID   SC6A9_HUMAN             Reviewed;         706 AA.
AC   P48067; A6NDH1; A6NII2; A6NNZ8; Q5TAB8; Q5TAB9; Q5TAC0;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   10-AUG-2010, sequence version 3.
DT   10-MAY-2017, entry version 146.
DE   RecName: Full=Sodium- and chloride-dependent glycine transporter 1;
DE            Short=GlyT-1;
DE            Short=GlyT1;
DE   AltName: Full=Solute carrier family 6 member 9;
GN   Name=SLC6A9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS GLYT-1A; GLYT-1B AND GLYT-1C).
RC   TISSUE=Brain;
RX   PubMed=8183239;
RA   Kim K.-M., Kingsmore S.F., Han H., Yang-Feng T.L., Godinot N.,
RA   Seldin M.F., Caron M.G., Giros B.;
RT   "Cloning of the human glycine transporter type 1: molecular and
RT   pharmacological characterization of novel isoform variants and
RT   chromosomal localization of the gene in the human and mouse genomes.";
RL   Mol. Pharmacol. 45:608-617(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-698, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [5]
RP   INVOLVEMENT IN GCENSG.
RX   PubMed=27773429; DOI=10.1016/j.ajhg.2016.09.004;
RA   Kurolap A., Armbruster A., Hershkovitz T., Hauf K., Mory A.,
RA   Paperna T., Hannappel E., Tal G., Nijem Y., Sella E., Mahajnah M.,
RA   Ilivitzki A., Hershkovitz D., Ekhilevitch N., Mandel H., Eulenburg V.,
RA   Baris H.N.;
RT   "Loss of Glycine Transporter 1 Causes a Subtype of Glycine
RT   Encephalopathy with Arthrogryposis and Mildly Elevated Cerebrospinal
RT   Fluid Glycine.";
RL   Am. J. Hum. Genet. 99:1172-1180(2016).
RN   [6]
RP   VARIANT GCENSG GLY-407, AND INVOLVEMENT IN GCENSG.
RX   PubMed=27481395; DOI=10.1007/s00439-016-1719-x;
RA   Alfadhel M., Nashabat M., Qahtani H.A., Alfares A., Mutairi F.A.,
RA   Shaalan H.A., Douglas G.V., Wierenga K., Juusola J., Alrifai M.T.,
RA   Arold S.T., Alkuraya F., Ali Q.A.;
RT   "Mutation in SLC6A9 encoding a glycine transporter causes a novel form
RT   of non-ketotic hyperglycinemia in humans.";
RL   Hum. Genet. 135:1263-1268(2016).
CC   -!- FUNCTION: Terminates the action of glycine by its high affinity
CC       sodium-dependent reuptake into presynaptic terminals. May play a
CC       role in regulation of glycine levels in NMDA receptor-mediated
CC       neurotransmission.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=GlyT-1C;
CC         IsoId=P48067-1; Sequence=Displayed;
CC       Name=GlyT-1A;
CC         IsoId=P48067-2; Sequence=VSP_006270;
CC       Name=GlyT-1B;
CC         IsoId=P48067-3; Sequence=VSP_006271;
CC   -!- TISSUE SPECIFICITY: Isoform GlyT-1A and isoform GlyT-1B can be
CC       found in brain, kidney, pancreas, lung, placenta and liver but
CC       isoform GlyT-1C is only found in brain.
CC   -!- DISEASE: Glycine encephalopathy with normal serum glycine (GCENSG)
CC       [MIM:617301]: An autosomal recessive, severe metabolic disorder
CC       characterized by arthrogryposis multiplex congenita, joint
CC       hyperlaxity, lack of neonatal respiratory effort, axial hypotonia,
CC       hypertonia with pronounced clonus, and delayed psychomotor
CC       development. Some patients may have dysmorphic facial features
CC       and/or brain imaging abnormalities. Laboratory studies show
CC       increased CSF glycine and normal or only mildly increased serum
CC       glycine. Most patients die in infancy.
CC       {ECO:0000269|PubMed:27481395, ECO:0000269|PubMed:27773429}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the sodium:neurotransmitter symporter (SNF)
CC       (TC 2.A.22) family. SLC6A9 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB30784.1; Type=Frameshift; Positions=8; Evidence={ECO:0000305};
CC       Sequence=AAB30785.1; Type=Frameshift; Positions=8; Evidence={ECO:0000305};
CC       Sequence=CAI19428.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAI19429.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S70609; AAB30784.1; ALT_FRAME; mRNA.
DR   EMBL; S70612; AAB30785.1; ALT_FRAME; mRNA.
DR   EMBL; AL139220; CAI19428.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AL139220; CAI19429.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AL139220; CAI19430.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07056.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07057.1; -; Genomic_DNA.
DR   CCDS; CCDS30695.1; -. [P48067-2]
DR   CCDS; CCDS41316.1; -. [P48067-3]
DR   CCDS; CCDS41317.1; -. [P48067-1]
DR   PIR; I57956; I57956.
DR   PIR; I77912; I77912.
DR   RefSeq; NP_001020016.1; NM_001024845.2. [P48067-2]
DR   RefSeq; NP_001315558.1; NM_001328629.1. [P48067-2]
DR   RefSeq; NP_008865.2; NM_006934.3. [P48067-3]
DR   RefSeq; NP_964012.2; NM_201649.3. [P48067-1]
DR   UniGene; Hs.442590; -.
DR   ProteinModelPortal; P48067; -.
DR   BioGrid; 112427; 5.
DR   IntAct; P48067; 4.
DR   STRING; 9606.ENSP00000353791; -.
DR   BindingDB; P48067; -.
DR   ChEMBL; CHEMBL2337; -.
DR   DrugBank; DB00145; Glycine.
DR   GuidetoPHARMACOLOGY; 935; -.
DR   TCDB; 2.A.22.2.12; the neurotransmitter:sodium symporter (nss) family.
DR   iPTMnet; P48067; -.
DR   PhosphoSitePlus; P48067; -.
DR   BioMuta; SLC6A9; -.
DR   DMDM; 302393807; -.
DR   MaxQB; P48067; -.
DR   PaxDb; P48067; -.
DR   PeptideAtlas; P48067; -.
DR   PRIDE; P48067; -.
DR   DNASU; 6536; -.
DR   Ensembl; ENST00000357730; ENSP00000350362; ENSG00000196517. [P48067-3]
DR   Ensembl; ENST00000360584; ENSP00000353791; ENSG00000196517. [P48067-1]
DR   Ensembl; ENST00000372310; ENSP00000361384; ENSG00000196517. [P48067-2]
DR   GeneID; 6536; -.
DR   KEGG; hsa:6536; -.
DR   UCSC; uc001cll.5; human. [P48067-1]
DR   CTD; 6536; -.
DR   DisGeNET; 6536; -.
DR   GeneCards; SLC6A9; -.
DR   HGNC; HGNC:11056; SLC6A9.
DR   HPA; HPA013977; -.
DR   MIM; 601019; gene.
DR   MIM; 617301; phenotype.
DR   neXtProt; NX_P48067; -.
DR   OpenTargets; ENSG00000196517; -.
DR   PharmGKB; PA35916; -.
DR   eggNOG; KOG3659; Eukaryota.
DR   eggNOG; COG0733; LUCA.
DR   GeneTree; ENSGT00760000118857; -.
DR   HOVERGEN; HBG071421; -.
DR   InParanoid; P48067; -.
DR   KO; K05038; -.
DR   OrthoDB; EOG091G08PX; -.
DR   PhylomeDB; P48067; -.
DR   TreeFam; TF343812; -.
DR   Reactome; R-HSA-442660; Na+/Cl- dependent neurotransmitter transporters.
DR   ChiTaRS; SLC6A9; human.
DR   GeneWiki; Glycine_transporter_1; -.
DR   GenomeRNAi; 6536; -.
DR   PRO; PR:P48067; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000196517; -.
DR   CleanEx; HS_SLC6A9; -.
DR   ExpressionAtlas; P48067; baseline and differential.
DR   Genevisible; P48067; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0015375; F:glycine:sodium symporter activity; TAS:Reactome.
DR   GO; GO:0005328; F:neurotransmitter:sodium symporter activity; IEA:InterPro.
DR   GO; GO:0005215; F:transporter activity; IBA:GO_Central.
DR   GO; GO:0061537; P:glycine secretion, neurotransmission; IEA:Ensembl.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   InterPro; IPR000175; Na/ntran_symport.
DR   InterPro; IPR003028; Na/ntran_symport_glycine_GLY1.
DR   PANTHER; PTHR11616; PTHR11616; 1.
DR   Pfam; PF00209; SNF; 1.
DR   PRINTS; PR01204; GLY1TRNSPORT.
DR   PRINTS; PR00176; NANEUSMPORT.
DR   PROSITE; PS00610; NA_NEUROTRAN_SYMP_1; 1.
DR   PROSITE; PS00754; NA_NEUROTRAN_SYMP_2; 1.
DR   PROSITE; PS50267; NA_NEUROTRAN_SYMP_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Amino-acid transport; Complete proteome;
KW   Disease mutation; Membrane; Neurotransmitter transport;
KW   Phosphoprotein; Reference proteome; Symport; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    706       Sodium- and chloride-dependent glycine
FT                                transporter 1.
FT                                /FTId=PRO_0000214780.
FT   TOPO_DOM      1    108       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    109    129       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM    136    156       Helical; Name=2. {ECO:0000255}.
FT   TRANSMEM    188    208       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    209    285       Extracellular. {ECO:0000255}.
FT   TRANSMEM    286    306       Helical; Name=4. {ECO:0000255}.
FT   TRANSMEM    315    335       Helical; Name=5. {ECO:0000255}.
FT   TRANSMEM    360    380       Helical; Name=6. {ECO:0000255}.
FT   TRANSMEM    407    427       Helical; Name=7. {ECO:0000255}.
FT   TRANSMEM    450    470       Helical; Name=8. {ECO:0000255}.
FT   TRANSMEM    506    526       Helical; Name=9. {ECO:0000255}.
FT   TRANSMEM    530    550       Helical; Name=10. {ECO:0000255}.
FT   TRANSMEM    570    590       Helical; Name=11. {ECO:0000255}.
FT   TRANSMEM    610    630       Helical; Name=12. {ECO:0000255}.
FT   TOPO_DOM    631    706       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES     673    673       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P28571}.
FT   MOD_RES     698    698       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     83       MSGGDTRAAIARPRMAAAHGPVAPSSPEQVTLLPVQRSFFL
FT                                PPFSGATPSTSLAESVLKVWHGAYNSGLLPQLMAQHSLAMA
FT                                Q -> MVGKGAKGML (in isoform GlyT-1A).
FT                                {ECO:0000303|PubMed:8183239}.
FT                                /FTId=VSP_006270.
FT   VAR_SEQ      29     82       Missing (in isoform GlyT-1B).
FT                                {ECO:0000303|PubMed:8183239}.
FT                                /FTId=VSP_006271.
FT   VARIANT     407    407       S -> G (in GCENSG).
FT                                {ECO:0000269|PubMed:27481395}.
FT                                /FTId=VAR_078074.
FT   CONFLICT    373    373       G -> A (in Ref. 1; AAB30784/AAB30785).
FT                                {ECO:0000305}.
FT   CONFLICT    682    682       P -> S (in Ref. 1; AAB30784/AAB30785).
FT                                {ECO:0000305}.
SQ   SEQUENCE   706 AA;  78260 MW;  654B208568F843F4 CRC64;
     MSGGDTRAAI ARPRMAAAHG PVAPSSPEQV TLLPVQRSFF LPPFSGATPS TSLAESVLKV
     WHGAYNSGLL PQLMAQHSLA MAQNGAVPSE ATKRDQNLKR GNWGNQIEFV LTSVGYAVGL
     GNVWRFPYLC YRNGGGAFMF PYFIMLIFCG IPLFFMELSF GQFASQGCLG VWRISPMFKG
     VGYGMMVVST YIGIYYNVVI CIAFYYFFSS MTHVLPWAYC NNPWNTHDCA GVLDASNLTN
     GSRPAALPSN LSHLLNHSLQ RTSPSEEYWR LYVLKLSDDI GNFGEVRLPL LGCLGVSWLV
     VFLCLIRGVK SSGKVVYFTA TFPYVVLTIL FVRGVTLEGA FDGIMYYLTP QWDKILEAKV
     WGDAASQIFY SLGCAWGGLI TMASYNKFHN NCYRDSVIIS ITNCATSVYA GFVIFSILGF
     MANHLGVDVS RVADHGPGLA FVAYPEALTL LPISPLWSLL FFFMLILLGL GTQFCLLETL
     VTAIVDEVGN EWILQKKTYV TLGVAVAGFL LGIPLTSQAG IYWLLLMDNY AASFSLVVIS
     CIMCVAIMYI YGHRNYFQDI QMMLGFPPPL FFQICWRFVS PAIIFFILVF TVIQYQPITY
     NHYQYPGWAV AIGFLMALSS VLCIPLYAMF RLCRTDGDTL LQRLKNATKP SRDWGPALLE
     HRTGRYAPTI APSPEDGFEV QPLHPDKAQI PIVGSNGSSR LQDSRI
//
